11/9/26 Accelerate RARE Working Group B: Pediatric Trial Readiness Blueprint (Ron Bartek) Next OPENING KEYNOTE - From Breakthrough to Access: How Advocacy and Policy Decide What Reaches Patients. You Might Also Like Bridging the Generational Divide in Rare Disease Clinical Trials: Tailoring Communication to Maximize Recruitment, Retention, and Equity Patient Input and Digital Health Technologies: A Regulatory Perspective Across the Product Lifecycle OPENING KEYNOTE - From Breakthrough to Access: How Advocacy and Policy Decide What Reaches Patients. From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment Mapping the Rare Patient Journey
11/9/26 Accelerate RARE Working Group B: Pediatric Trial Readiness Blueprint (Ron Bartek) Next OPENING KEYNOTE - From Breakthrough to Access: How Advocacy and Policy Decide What Reaches Patients. You Might Also Like Bridging the Generational Divide in Rare Disease Clinical Trials: Tailoring Communication to Maximize Recruitment, Retention, and Equity Patient Input and Digital Health Technologies: A Regulatory Perspective Across the Product Lifecycle OPENING KEYNOTE - From Breakthrough to Access: How Advocacy and Policy Decide What Reaches Patients. From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment Mapping the Rare Patient Journey
